Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evaxion Biotech A/S

2.45
-0.1350-5.22%
Volume:47.54K
Turnover:122.58K
Market Cap:15.48M
PE:-0.41
High:2.69
Open:2.61
Low:2.43
Close:2.59
Loading ...

BRIEF-Evaxion A/S Expands Research And Development Pipeline With New Vaccine Program Targeting Group A Streptococcus

Reuters
·
25 Jun

Evaxion a/S: Expands R&D Pipeline With New Vaccine Program Targeting Group a Streptococcus

THOMSON REUTERS
·
25 Jun

European Equities Traded in the US as American Depositary Receipts Retreat Friday

MT Newswires Live
·
20 Jun

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT Newswires Live
·
17 Jun

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
16 Jun

European Equities Traded in the US as American Depositary Receipts Slide Friday

MT Newswires Live
·
13 Jun

European Equities Traded in the US as American Depositary Receipts Rise Wednesday

MT Newswires Live
·
11 Jun

European Equities Traded in the US as American Depositary Receipts Edge Higher Monday

MT Newswires Live
·
09 Jun

European Equities Traded in the US as American Depositary Receipts Advance Friday

MT Newswires Live
·
06 Jun

European Equities Traded in the US as American Depositary Receipts Rise Thursday

MT Newswires Live
·
05 Jun

Evaxion Receives Grant Funding to Design New Polio Vaccine

THOMSON REUTERS
·
03 Jun

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
02 Jun

European Equities Traded in the US as American Depositary Receipts Modestly Higher in Thursday Trading

MT Newswires Live
·
29 May

European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading

MT Newswires Live
·
28 May

Evaxion Biotech: Promising Pipeline and Strategic Collaborations Drive Buy Rating

TIPRANKS
·
28 May

Evaxion A/S reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
27 May

Evaxion A/S Reports Q1 2025 Progress and Financial Results

TIPRANKS
·
27 May

Evaxion A/S Reports Q1 2025 Financial Results: Revenue at $0, Net Loss of $1,580K, EPS at $(0.01)

Reuters
·
27 May

Evaxion Biotech Q1 GAAP EPS $(0.01) Beats $(0.65) Estimate

Benzinga
·
27 May

BRIEF-Evaxion Biotech Q1 Basic EPS USD -0.01

Reuters
·
27 May